VitaNova Life Sciences (VNOV) Cash & Equivalents (2017 - 2026)
VitaNova Life Sciences (VNOV) reported Cash & Equivalents of $1.6 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 53.3% from $1.05 million a year earlier and up 0.4% from the prior quarter.
VitaNova Life Sciences (VNOV) Cash & Equivalents (2017 - 2026) Analysis & Trends
Dating back to fiscal Q4 2017, VitaNova Life Sciences' Cash & Equivalents record includes 24 quarters.
- Cash & Equivalents has a four-year compound annual growth rate of 188.4% (FY2022 to FY2026).
- By fiscal year, Cash & Equivalents came in at $782,810 in FY2025 (+32.0%), $593,036 in FY2024, $8,728 in FY2023 (-62.2%) and $23,103 in FY2022.
- The fiscal Q1 2027 figure ranks as the highest quarterly Cash & Equivalents in data going back to fiscal Q4 2017.
- Year over year, Cash & Equivalents has now increased in each of the last six quarters, with growth averaging 204.6% over the last seven quarters.
- The high point for year-over-year Cash & Equivalents in five years was fiscal Q1 2026 (growth of 639.0%); the low point was fiscal Q3 2023 (a decline of 70.2%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $1.6 million (Q4 2026), $1.17 million (Q3 2026) and $1.26 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 149.80 Bn | 109.09 Bn | 6.13 Bn | 10.17 Bn |
| 2 | Cintas | 89.51 Bn | 88.59 Bn | 1.55 Bn | 243.60 Mn |
| 3 | Iron Mountain | 33.10 Bn | 32.29 Bn | 1.07 Bn | 204.79 Mn |
| 4 | APi | 16.89 Bn | 13.93 Bn | 703.00 Mn | 851.00 Mn |
| 5 | Rollins | 16.57 Bn | 16.11 Bn | 582.90 Mn | 129.05 Mn |
| 6 | Gartner | 15.27 Bn | 8.96 Bn | 1.19 Bn | 1.49 Bn |
| 7 | UL Solutions | 14.70 Bn | 13.46 Bn | 417.00 Mn | 434.00 Mn |
| 8 | Aramark | 13.90 Bn | 11.85 Bn | 430.34 Mn | 499.43 Mn |
| 9 | Rentokil Initial | 11.45 Bn | 4.96 Bn | - | 2.47 Bn |
| 10 | VitaNova Life Sciences | 35.43 Mn | 29.80 Mn | 30,521.00 | 1.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.60 Mn |
| Apr 30, 2026 | 1.60 Mn |
| Jan 31, 2026 | 1.17 Mn |
| Oct 31, 2025 | 1.26 Mn |
| Jul 31, 2025 | 1.05 Mn |
| Apr 30, 2025 | 782,810.00 |
| Jan 31, 2025 | 405,173.00 |
| Oct 31, 2024 | 222,795.00 |
| Jul 31, 2024 | 141,635.00 |
| Apr 30, 2024 | 593,036.00 |
| Jan 31, 2024 | 808,356.00 |
| Apr 30, 2023 | 8,728.00 |
| Jan 31, 2023 | 11,013.00 |
| Oct 31, 2022 | 36,190.00 |
| Jul 31, 2022 | 29,884.00 |
| Apr 30, 2022 | 23,103.00 |
| Jan 31, 2022 | 36,935.00 |
| Oct 31, 2021 | 31,693.00 |
| Jan 31, 2019 | 50.00 |
| Oct 31, 2018 | 50.00 |
VitaNova Life Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VNOV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VNOV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VNOV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();